Barbara Melotti
Azienda USL di Bologna(IT)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Lung Cancer Research Studies
Most-Cited Works
- → Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain(2015)180 cited
- → Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme(2018)110 cited
- → Early palliative care and quality of life of advanced cancer patients—a multicenter randomized clinical trial(2019)79 cited
- → Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer(2004)73 cited
- → The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers(2019)67 cited
- → Oral melanoma and other pigmentations: when to biopsy?(2017)56 cited
- → Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study(2017)54 cited
- → Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma(2016)45 cited
- → CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors(2020)43 cited
- → Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)(2014)43 cited